sb 203580 has been researched along with scutellarin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (scutellarin) | Trials (scutellarin) | Recent Studies (post-2010) (scutellarin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 441 | 7 | 309 |
| Protein | Taxonomy | sb 203580 (IC50) | scutellarin (IC50) |
|---|---|---|---|
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HL; Han, H; Jia, WJ; Li, F; Li, HE; Li, JJ; Wu, CY; Yuan, Y; Zhang, XL | 1 |
1 other study(ies) available for sb 203580 and scutellarin
| Article | Year |
|---|---|
Scutellarin Exerts Anti-Inflammatory Effects in Activated Microglia/Brain Macrophage in Cerebral Ischemia and in Activated BV-2 Microglia Through Regulation of MAPKs Signaling Pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apigenin; Cerebral Cortex; Gene Expression Regulation; Glucuronates; Imidazoles; Infarction, Middle Cerebral Artery; Inflammation Mediators; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; Microglia; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2020 |